Who
Giles Richard Platford
President, IBU
Company insider
Files Form 4 as: President, IBU, Takeda Pharmaceutical Company.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $1.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Apr 2026
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $532K31,083 at $17.10 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $532K31,083 at $17.10 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —49,558 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —49,558 at $0.00 | filing |
| 27 Apr 2026filed 28 Apr 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —72,124 at $0.00 | filing |
| 27 Apr 2026filed 28 Apr 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —72,124 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.